Malonyl-CoA, fuel sensing, and insulin resistance

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 1 39-1, 1999, Pages

  Ruderman, Neil B ^a,c   Saha, Asish K ^a,c   Vavvas, Demetrios ^a   Witters, Lee A ^b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Acetyl CoA carboxylase; AMP activated protein kinase; Cytosolic citrate; Exercise; Glucose fatty acid cycle; Obesity; Protein kinase C

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CITRIC ACID; MALONYL COENZYME A; PROTEIN KINASE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; CYTOSOL; ENZYME REGULATION; ENZYME SUBSTRATE; EXERCISE; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; INSULIN RESISTANCE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 0032946302     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.1.e1     Document Type: Review

References (152)

1. Abu-Elheiga, L., D. B. Almarza-Ortega, A. Baldini, and S. J. Wakil. Human acetyl CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping and evidence for two isoforms. J. Biol. Chem. 272: 10669-10677, 1997.
2. Allred, J. B., and K. E. Reilly. Short-term regulation of acetyl CoA carboxylase in tissues of higher animals. Prog. Lipid Res. 35: 371-385, 1997.
3. Aragon, J. J., K. Tornheim, and J. M. Lowenstein. On a possible role of IMP in the regulation of phosphorylase activity in skeletal muscle. FEBS Lett. 117, Suppl.: K56-K64, 1980.
4. Astrup, A., B. Buemann, N. J. Christensen, and S. Toubro. Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E592-E599, 1994.
5. Avignon, A., K. Yamada, X. Zhou, B. Spencer, O. Cardona, S. Saba-Siddique, L. Galloway, M. L. Standaert, and R. V. Farese. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis. Diabetes 45: 1396-1404, 1996.
6. Awan, M. M., and E. D. Saggerson. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. Biochem. J. 295: 61-66, 1993.
7. Bai, Y., S. Zhang, K. S. Kim, J. K. Lee, and K. H. Kim. Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J. Biol. Chem. 271: 13939-13942, 1996.
8. Barthel, A., K. Nakatani, A. Dandekar, and R. A. Roth. Protein kinase C modulates the insulin-stimulated increase in Akt1 and Akt3 activity in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 243: 509-513, 1998.
9. Bavenholm, P., G. Pigon, A. Saha, N. Ruderman, and S. Efendic. Fatty acid oxidation in humans is regulated by malonyl CoA in muscle. Diabetologia 41, Suppl. 1: A25, 1998.
10. Berger, M., S. A. Hagg, M. B. Goodman, and N. B. Ruderman. Glucose metabolism in perfused skeletal muscle: effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem. J. 158: 191-202, 1976.
11. Bianchi, A., J. Evans, A. Iverson, A. Nordlund, T. Watts, and L. Witters. Identification of an isozymic form of acetyl-CoA carboxylase. J. Biol. Chem. 265: 1502-1509, 1990.
12. Bjorntorp, P. Metabolic implications of body fat distribution. Diabetes Care 14: 1132-1143, 1991.
13. 2+-mobilizing hormones: studies using phospholipase C and phorbol myristate acetate. Biochem. J. 237: 235-242, 1986.
14. Boden, G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10, 1997.
15. Boden, G., and F. Jadal. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 88: 960-966, 1991.
16. Bokyo, E. J., D. L. Leonetti, R. W. Bergstrom, L. Newell-Morris, and W. Y. Fujimoto. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity: 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 45: 1010-1015, 1996.
17. Bray, G. A. Obesity: a disorder of nutrient partitioning: the MONA LISA hypothesis. J. Nutr. 121: 1146-1162, 1991.
18. Caro, J. F. Clinical review: insulin resistance in obese and nonobese man. J. Clin. Endocrinol. Metab. 73: 691-695, 1991.
19. Chang, S., B. Graham, F. Yakubu, D. Lin, J. C. Peters, and J. O. Hill. Metabolic differences between obesity-prone and obesity-resistant rats. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol. 28): R1103-R1110, 1990.
20. Chappell, J. B. Systems used for the transport of substrates into mitochondria. Br. Med. Bull. 24: 150-156, 1968.
21. Cheema-Dhadli, S., B. H. Robinson, and M. L. Halperin. Properties of the citrate transporter in rat heart: implications for regulation of glycolysis by cytosolic citrate. Can. J. Biochem. 54: 561-565, 1976.
22. Chen, S., A. Ogawa, M. Ohneda, R. H. Unger, D. W. Foster, and J. D. McGarry. More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes 43: 878-883, 1994.
23. Corkey, B. E., M. C. Glennon, K. S. Chen, J. T. Deeney, F. M. Matschinsky, and M. Prentki. A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic beta-cells. J. Biol. Chem. 264: 21608-21612, 1989.
24. Corton, J. M., J. G. Gillespie, S. A. Hawley, and D. G. Hardie. 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating protein kinase in intact cells? Eur. J. Biochem. 229: 558-565, 1995.
25. Davies, S. P., D. Carling, M. R. Munday, and D. G. Hardie. Diurinal rhythm of phosphorylation of rat liver acetyl CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets. Eur. J. Biochem. 203: 615-623, 1992.
26. Dean, D., D. Chien, A. Saha, T. Kurowski, D. Vavvas, and J. P. Flatt. Malonyl CoA acutely regulates fatty acid oxidation in rat muscle in vivo (Abstract). Diabetes 47: A279, 1998.
27. Devlin, J. T., M. Hirshman, E. D. Horton, and E. S. Horton. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes 36: 434-439, 1987.
28. Donnelly, R., M. J. Reed, S. Azhar, and G. M. Reaven. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 135: 2369-2374, 1994.
29. Duan, C., and W. W. Winder. Nerve stimulation decreases malonyl-CoA in skeletal muscle. J. Appl. Physiol. 72: 901-904, 1992.
30. Dudley, G. A., and R. L. Terjung. Influence of acidosis on AMP deaminase activity in contracting fast-twitch muscle. Am. J. Physiol. 248 (Cell Physiol. 17): C43-C50, 1985.
31. Dyck, J., G. Gao, J. Widmer, D. Stapleton, C. S. Fernandez, B. E. Kemp, and L. A. Witters. Regulation of 5′-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J. Biol. Chem. 271: 17798-17803, 1996.
32. Filippis, A., S. Clark, and J. Proietto. Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C. Biochem. J. 324: 981-985, 1997.
33. Flatt, J. P. Substrate utilization and obesity. Diabetes Rev. 4: 433-449, 1996.
34. Flatt, J. P., E. Ravussin, K. J. Acheson, and E. Jequier. Effects of dietary fat on postprandial substrate oxidation and on carbohydrate and fat balances. J. Clin. Invest. 76: 1019-1024, 1985.
35. Flatt, J. P. I. McCollum Award Lecture, 1995: Diet, lifestyle, and weight maintenance. Am. J. Clin. Nutr. 62: 820-836, 1995.
36. Flier, J. S. Leptin expression and action: new experimental paradigms. Proc. Natl. Acad. Sci. USA 94: 4242-4245, 1997.
37. Foley, J. E. Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15: 773-784, 1992.
38. Gammeltoft, A. The significance of ketone bodies in fat metabolism. I. Concentration of ketone bodies in arterial and venous blood of human subjects during starvation. Acta Phys. Scand. 19: 270-279, 1950.
39. Gao, G., D. Stapleton, A. S. Auster, S. C. Fernandez, J. Widmer, B. E. Kemp, and L. A. Witters. Non-catalytic beta and gamma subunit isoforms of the 5′-AMP-activated protein kinase. J. Biol. Chem. 271: 8675-8681, 1996.
40. Gao, G., J. Widmer, D. Stapleton, T. Teh, T. Cox, B. E. Kemp, and L. A. Witters. The catalytic subunit of the 5′-AMP-activated protein kinase: cDNA cloning and mRNA distribution. Biochim. Biophys. Acta 1266: 73-82, 1995.
41. Garland, P. B., and P. J. Randle. Regulation of glucose uptake by muscle. 10. Effects of alloxan diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl coenzyme A, glycerol phosphate and citric acid cycle intermediates in rat heart and diaphragm muscle. Biochem. J. 93: 678-687, 1964.
42. Goodridge, A. G. Regulation of fatty acid synthesis in isolated hepatocytes. Evidence for a physiological role for long chain fatty acyl coenzyme A and citrate. J. Biol. Chem. 248: 4318-4326, 1973.
43. Groop, L. C., C. Saloranta, E. Ferrannini, and R. A. DeFronzo. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 72: 96-107, 1991.
44. Ha, J., S. Daniel, S. S. Broyles, and K. H. Kim. Critical phosphorylation sites for acetyl-CoA carboxylase activity. J. Biol. Chem. 269: 22162-22168, 1994.
45. Ha, J., J. K. Lee, K. S. Kim, L. A. Witters, and K. H. Kim. Cloning of human acetyl-CoA carboxylase-beta and its unique features. Proc. Natl. Acad. Sci. USA 93: 11466-11470, 1996.
46. Hagg, S. A., S. I. Taylor, and N. B. Ruderman. Glucose metabolism in perfused skeletal muscle. Pyruvate dehydrogenase activity in starvation, diabetes, and exercise. Biochemistry 158: 203-210, 1976.
47. Hardie, D. G. Regulation of fatty acid synthesis via phosphorylation of acetyl CoA carboxylase. Prog. Lipid Res. 28: 117-146, 1989.
48. Hardie, D. G., and D. Carling. The AMP-activated protein kinase. Fuel gauge of the mammalian cell. Eur. J. Biochem. 246: 259-273, 1997.
49. Hawkins, M., N. Barzilai, R. Liu, M. Hu, W. Chen, and L. Rossetti. Role of the glucosamine pathway in fat-induced insulin resistance. J. Clin. Invest. 99: 2173-2182, 1997.
50. Hayashi, T., M. F. Hirshman, E. Kurth, W. W. Winder, and L. J. Goodyear. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
51. Heydrick, S. J., N. B. Ruderman, T. G. Kurowski, H. B. Adams, and K. S. Chen. Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle. Altered protein kinase C activity and possible link to insulin resistance. Diabetes 40: 1707-1711, 1991.
52. Iacobazzi, V., A. De Palma, and F. Palmieri. Cloning and sequencing of the bovine cDNA encoding the mitochondrial tricarboxylate carrier protein. Biochim. Biophys. Acta 1284: 9-12, 1996.
53. Jang, S. H., T. M. Cheesbrough, and P. E. Kolattukudy. Molecular cloning, nucleotide sequence, and tissue distribution of malonyl-CoA decarboxylase. J. Biol. Chem. 264: 3500-3505, 1989.
54. Kamohara, S., R. Burcelin, J. L. Halaas, J. M. Friedman, and M. J. Charron. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377, 1997.
55. Kelley, D. E., M. Mokan, J. A. Simoneau, and L. J. Mandarino. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 92: 91-98, 1993.
56. Kim, J. K., J. K. Wi, and J. H. Youn. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45: 446-453, 1996.
57. Kim, K. H. Regulation of mammalian acetyl-coenzyme A carboxylase. Annu. Rev. Nutr. 17: 77-99, 1997.
58. Kim, K. H., C. F. Lopez, D. H. Bai, X. Luo, and M. E. Pape. Role of reversible phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis. FASEB J. 3: 2250-2256, 1989.
59. Kissebah, A. H. Central obesity: measurement and metabolic effects. Diabetes Rev. 5: 8-20, 1997.
60. Kruszynska, Y. T., and J. M. Olefsky. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J. Invest. Med. 44: 413-428, 1996.
61. Kudo, N., A. Barr, R. Barr, S. Desai, and G. Lopaschuk. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 270: 17513-17520, 1995.
62. Kurowski, T. G., A. K. Saha, B. A. Cunningham, R. I. Holbert, J. R. Colca, B. E. Corkey, and N. B. Ruderman. Malonyl coenzyme A and adiposity in the Dahl salt-sensitive rat: effects of pioglitazone. Metabolism 45: 519-525, 1996.
63. Laybutt, D. R., S. Schmitz-Peiffer, N. B. Ruderman, D. Chisholm, T. Biden, and E. W. Kraegen. Activation of protein kinase C∈ may contribute to muscle insulin resistance induced by lipid accumulation during chronic glucose infusion in rats (Abstract). Diabetes 46: 241A, 1997.
64. Lopaschuk, G. D., L. A. Witters, T. Itoi, R. Barr, and A. Barr. Acetyl CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart. J. Biol. Chem. 269: 25871-25878, 1994.
65. Louis, N. A., and L. A. Witters. Glucose regulation of acetyl-CoA carboxylase in hepatoma and islet cells. J. Biol. Chem. 267: 2287-2293, 1992.
66. Maizels, E. Z., N. B. Ruderman, M. N. Goodman, and D. Lau. Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem. J. 162: 557-568, 1977.
67. Mandarino, L. J., A. Consoli, A. Jain, and D. E. Kelley. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E463-E470, 1996.
68. McClain, D. A., and E. D. Crook. Hexosamines and insulin resistance. Diabetes 45: 1003-1009, 1996.
69. McGarry, J., and N. Brown. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244: 1-14, 1997.
70. McGarry, J., S. Mills, C. Long, and D. Foster. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase 1 in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem. J. 214: 21-28, 1983.
71. McGarry, J. D. What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258: 766-770, 1993.
72. McGarry, J. D. The mitochondrial carnitine palmitoyl-transferase system: its broadening role in fuel homoeostasis and new insights into its molecular features. Biochem. Soc. Trans. 23: 321-324, 1995.
73. McGarry, J. D., G. F. Leatherman, and D. W. Foster. Carnitine palmitoyltransferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl-CoA. J. Biol. Chem. 253: 4128-4136, 1978.
74. Merrill, G. F., E. J. Kurth, D. G. Hardie, and W. W. Winder. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E1107-E1112, 1997.
75. Michell, B. J., D. Stapleton, K. I. Mitchelhill, C. House, F. Katsis, L. A. Witters, and B. E. Kemp. Isoform-specific purification and substrate specificity of the 5′-AMP-activated protein kinase. J. Biol. Chem. 271: 28445-28450, 1996.
76. Mills, S. E., D. W. Foster, and J. D. McGarry. Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase 1. Biochem. J. 214: 83-91, 1983.
77. Mitchellhill, K. I., B. J. Michell, C. M. House, D. Stapleton, L. A. Witters, and B. E. Kemp. Posttranslational modifications of the 5′-AMP-activated protein kinase betal subunit. J. Biol. Chem. 272: 24475-24479, 1997.
78. Mitchellhill, K. I., D. A. Stapelton, G. Gao, C. House, B. Michell, L. A. Witters, and B. E. Kemp. Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast snf1 protein kinase. J. Biol. Chem. 269: 2361-2364, 1994.
79. Moir, A. M., and V. A. Zammit. Rapid switch of hepatic fatty acid metabolism from oxidation to esterification during diurnal feeding of meal-fed rats correlates with changes in the properties of acetyl-CoA carboxylase, but not of carnitine palmitoyl-transferase 1. Biochem. J. 291: 241-246, 1993.
80. Muller, H. K., M. Kellerer, B. Ermel, A. Muhlhofer, K. B. Obermaier, B. Vogt, and H. U. Haring. Prevention by protein kinase C inhibitors of glucose-induced insulin-receptor tyrosine kinase resistance in rat fat cells. Diabetes 40: 1440-1448, 1991.
81. Munday, M. R., M. R. Milic, M. C. Sugden, S. Takhar, and M. C. Holness. The short term regulation of hepatic acetyl CoA carboxylase during starvation and refeeding in the rat. Biochemistry 280: 733-737, 1991.
82. Muoio, D. M., G. L. Dohm, F. T. Fiedorek, E. B. Tapscott, and R. A. Coleman. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46: 1360-1363, 1997.
83. Neel, J. V. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress." Am. J. Human Genet. 14: 352-362, 1962.
84. Newgard, C. B., and J. D. McGarry. Metabolic coupling factors in pancreatic beta-cell signal transduction. Annu. Rev. Biochem. 64: 689-719, 1995.
85. Newsholme, E. A., and A. R. Leech. Regulation of glucose and fatty acid oxidation in relation to energy demand in muscle. In: Biochemistry for the Medical Sciences. Chichester, UK: Wiley, 1983, p. 300-335.
86. Oakes, N. D., K. S. Bell, S. M. Furler, S. Camilleri, A. K. Saha, N. B. Ruderman, D. J. Chisholm, and E. W. Kraegen. Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: parallel relationship between insulin stimulation of glucose uptake and suppression of long chain fatty acyl-CoA. Diabetes 46: 2022-2028, 1997.
87. Oakes, N. D., S. Camilleri, S. M. Furler, D. J. Chisholm, and E. W. Kraegen. The antidiabetic agent, BRL 49653, reduces nonesterified fatty acid utilisation and tissue lipid availability in the rat. Metabolism 46: 935-942, 1997.
88. Odeleye, O. E., M. de Courten, D. J. Pettitt, and E. Ravussin. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 48: 1341-1345, 1997.
89. Odland, L. M., G. J. F. Heigenhauser, G. D. Lopaschuk, and L. L. Spriet. Human skeletal muscle malonyl-CoA at rest and during prolonged submaximal exercise. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E541-E544, 1996.
90. Owen, O. E., and G. A. J. Reichard. Human forearm metabolism during progressive starvation. J. Clin. Invest. 50: 1536-1545, 1971.
91. Pan, D. A., S. Lillioja, A. D. Kriketos, M. R. Milner, L. A. Baur, C. Bogardus, A. B. Jenkins, and L. H. Storlien. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
92. Pillay, T. S., S. Xiao, and J. M. Olefsky. Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites. J. Clin. Invest. 97: 613-620, 1996.
93. Ponticos, M., Q. L. Lu, J. E. Morgan, D. G. Hardie, T. A. Partridge, and D. Carling. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in muscle. EMBO J. 17: 1688-1699, 1998.
94. Prentki, M., and B. E. Corkey. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45: 273-283, 1996.
95. Prentki, M., S. Vischer, M. Glennon, R. Regazzi, J. Deeney, and B. Corkey. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J. Biol. Chem. 267: 5802-5810, 1992.
96. Randle, P. J., P. B. Garland, C. N. Hales, and E. A. Newsholme. The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
97. Randle, P. J., P. B. Garland, C. N. Hales, E. A. Newsholme, R. M. Denton, and C. I. Pogson. Interactions of metabolism and the physiological role of insulin. Recent Prog. Horm. Res. 22: 1-48, 1966.
98. Randle, P. J., D. A. Priestman, S. C. Mistry, and A. Halsall. Glucose fatty acid interactions and the regulation of glucose disposal. J. Cell. Biochem. 55: 1-11, 1994.
99. Ravussin, E., and B. A. Swinburn. Energy expenditure and obesity. Diabetes Rev. 4: 403-422, 1996.
100. Reaven, G. M. Role of insulin resistance in human diabetes. Diabetes 37: 1595-1607, 1988.
101. Richter, E. A., L. P. Garetto, M. N. Goodman, and N. B. Ruderman. Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. J. Clin. Invest. 69: 785-793, 1982.
102. Roche, E., S. Farfari, L. A. Witters, F. Assimacopolous-Jeannet, S. Thumelin, T. Brun, B. E. Corkey, A. K. Saha, and M. Prentki. Long term exposure of B (INS) cells to high glucose concentrations increases anaplerosis, lipogenesis and lipogenic gene expression. Diabetes 47: 1086-1094, 1998.
103. Ruderman, N., D. Chisholm, X. Pi-Sunyer, and S. Schneider. The metabolically obese, normal-weight individual: revisited. Diabetes 47: 699-713, 1998.
104. Ruderman, N. B., and M. N. Goodman. Regulation of ketone-body metabolism in skeletal muscle. Am. J. Physiol. 224: 1391-1397, 1973.
105. Ruderman, N. B., C. R. S. Houghton, and R. A. Hems. Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem. J. 124: 639-651, 1971.
106. Ruderman, N. B., E. Z. Maizels, M. Rabban, and M. N. Goodman. Interaction between ketone-body and carbohydrate metabolism in peripheral tissue. FEBS Symposium. Regulatory Mechanisms of Carbohydrate Metabolism, edited by V. Esmann. New York: Pergamon, 1978, vol. 42, p. 193-203.
107. Ruderman, N. B., P. S. Ross, M. Berger, and M. N. Goodman. Regulation of glucose and ketone body metabolism in rat brain of anaesthetized rats. Biochem. J. 138: 1-10, 1974.
108. Ruderman, N. B., A. K. Saha, D. Vavvas, S. J. Heydrick, and T. G. Kurowski. Lipid abnormalities in muscle of insulin-resistant rodents. The malonyl CoA hypothesis. Ann. NY Acad. Sci. 827: 221-230, 1997.
109. Ruderman, N. B., A. K. Saha, D. Vavvas, T. Kurowski, D. R. Laybutt, C. Schmitz-Peiffer, T. Biden, and E. W. Kraegen. Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity. In: Advances in Experimental Medicine and Biology. Metabolism in Skeletal Muscle Exercise and Diabetes, edited by E. A. Richter, B. Kiens, H. Galbo, and B. Saltin. New York: Plenum, 1998, vol. 441, p. 263-270.
110. Ruderman, N. B., C. J. Toews, and E. Shafrir. Role of free fatty acids in glucose homeostasis. Arch. Int. Med. 123: 299-313, 1969.
111. Saad, M. J. A., E. Araki, M. Miralpeix, P. L. Rothenberg, M. F. White, and C. R. Kahn. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J. Clin. Invest. 90: 1839-1849, 1992.
112. Saddik, M., J. Gamble, L. A. Witters, and G. D. Lopaschuk. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J. Biol. Chem. 268: 25836-25845, 1993.
113. Safer, B., and J. R. Williamson. Mitochondrial-cytosolic interactions in perfused rat heart. Role of coupled transamination in repletion of citric acid cycle intermediates. J. Biol. Chem. 248: 2570-2579, 1973.
114. y mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol. Am. J. Physiol. 267 (Endocrinol. Metab. 30): E95-E101, 1994.
115. Saha, A. K., T. G. Kurowski, and N. B. Ruderman. A malonyl-CoA fuel-sensing mechanism in muscle: effects of insulin, glucose, and denervation. Am. J. Physiol. 269 (Endocrinol. Metab. 32): E283-E289, 1995.
116. Saha, A. K., D. Vavvas, T. G. Kurowski, A. Apazidis, L. A. Witters, E. Shafrir, and N. B. Ruderman. Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E641-E648, 1997.
117. Saha, A. K., D. Vavvas, D. Laybutt, D. Chisholm, E. Kraegen, and N. Ruderman. Increases in cytosolic citrate regulate malonyl CoA levels in insulin-resistant muscles in vivo (Abstract). Diabetes 46: 235A, 1997.
118. Sato, K., Y. Kashiwaya, C. A. Keon, N. Tsuchiya, M. T. King, G. K. Radda, B. Chance, K. Clarke, and R. L. Veech. Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9: 651-658, 1995.
119. Schemmel, R., O. Mickelsen, and J. L. Gill. Dietary obesity in rats: body weight and fat accretion in seven strains of rats. J. Nutr. 100: 1041-1048, 1970.
120. Schmitz-Peiffer, C., C. L. Browne, N. D. Oakes, A. Watkinson, D. J. Chisholm, E. W. Kraegen, and T. J. Biden. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169-178, 1997.
121. Schmitz-Peiffer, C., N. D. Oakes, C. L. Browne, E. W. Kraegen, and T. J. Biden. Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E915-E921, 1997.
122. Shimabukuro, M., K. Koyama, G. Chen, M. Y. Wang, F. Trieu, Y. Lee, C. B. Newgard, and R. H. Unger. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA 94: 4637-4641, 1997.
123. Sidossis, L. S., C. A. Stuart, G. I. Shulman, G. D. Lopaschuk, and R. R. Wolfe. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J. Clin. Invest. 98: 2244-2250, 1996.
124. Spencer, A. F., and J. M. Lowenstein. Citrate content of liver and kidney of rat in various metabolic states and in fluoroacetate poisoning. Biochem. J. 103: 342-348, 1967.
125. Stapleton, D., G. Gao, B. J. Michell, J. Widmer, K. Mitchelhill, T. Teh, C. M. House, L. A. Witters, and B. E. Kemp. Mammalian 5′-AMP-activated protein kinase noncatalytic subunits are homologs of proteins that interact with yeast Snf 1 protein kinase. J. Biol. Chem. 269: 29343-29346, 1994.
126. Stapleton, D., K. I. Mitchelhill, G. Gao, J. Widmer, B. J. Michell, T. Teh, C. M. House, C. S. Farnandez, T. Cox, L. K. Witters, and B. E. Kemp. Mammalian AMP-activated protein kinase subfamily. J. Biol. Chem. 271: 611-614, 1996.
127. Stapleton, D., E. Woolatt, K. I. Mitchelhill, J. K. Nicholl, C. S. Fernandez, B. J. Michell, L. A. Witters, D. A. Power, G. R. Sutherland, and B. E. Kemp. AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett. 409: 452-456, 1997.
128. Stein, D. T., B. E. Stevenson, M. W. Chester, M. Basit, M. B. Daniels, S. D. Turley, and J. D. McGarry. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J. Clin. Invest. 100: 398-403, 1997.
129. Stryer, L. B. Glycolysis. In: Biochemistry (3rd ed.). New York: Freeman, 1988, chapt. 15, p. 359-361.
130. Sullivan, J. E., K. J. Brocklehurst, A. E. Marley, F. Carey, D. Carling, and R. K. Beri. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353: 33-36, 1994.
131. Thampy, K. Formation of malonyl coenzyme A in rat heart. Identification and purification of an isozyme of A carboxylase from rat heart. J. Biol. Chem. 264: 17631-17634, 1989.
132. Turinsky, J., D. M. O'Sullivan, and B. P. Bayly. 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J. Biol. Chem. 265: 16880-16885, 1990.
133. Ullrich, C., J. Widmer, J. P. Park, T. K. Mohandas, and L. A. Witters. Assignment of acetyl-CoA carboxylase-beta to human chromosome band 12q24.1 by in situ hybridization. Cytogenet. Cell. Gen. 77: 176-177, 1997.
134. Vavvas, D., A. Apazidis, A. K. Saha, J. Gamble, A. Patel, B. E. Kemp, L. A. Witters, and N. B. Ruderman. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J. Biol. Chem. 272: 13255-13261, 1997.
135. Wakil, S. J., J. K. Stoops, and V. C. Joshi. Fatty acid synthesis and its regulation. Annu. Rev. Biochem. 52: 537-579, 1983.
136. Walker, K. S., M. Deak, A. Paterson, K. Hudson, P. Cohen, and D. R. Alessi. Activation of protein kinase β and γ isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B α. Biochem. J. 331: 299-308, 1998.
137. Wang, J., R. Liu, M. Hu, J. Wu, N. Barzilai, L. Liu, and L. Rosetti. Effects of leptin on hepatic glucose fluxes and malonyl-CoA levels in the presence of basal insulin (Abstract). Diabetes 47: A27, 1998.
138. Widmer, J., K. S. Fassihi, S. C. Schlichter, K. S. Wheeler, B. E. Crote, N. King, N. Nutile McMenemy, W. W. Noll, S. Daniel, J. Ha, K. H. Kim, and L. A. Witters. Identification of a second human acetyl-CoA carboxylase gene. Biochem. J. 316: 915-922, 1996.
139. Winder, W. W., J. Arogyasami, I. M. Elayan, and D. Cartmill. Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E266-E271, 1990.
140. Winder, W. W., and D. G. Hardie. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E299-E304, 1996.
141. Winder, W. W., P. S. MacLean, J. C. Lucas, J. E. Fernley, and G. E. Trumble. Effect of fasting and refeeding on acetyl-CoA carboxylase in rat hindlimb muscle. J. Appl. Physiol. 78: 578-582, 1995.
142. Winder, W. W., H.A. Wilson, D. G. Hardie, B. B. Rasmussen, C. A. Hutber, G. B. Call, R. D. Clayton, L. M. Conley, S. Yoon, and B. Zhou. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J. Appl. Physiol. 82: 219-225, 1997.
143. Winz, R., D. Hess, R. Aebersold, and R. W. Brownsey. Unique structural features and differential phosphorylation of the 280-kDA component (isozyme) of rat liver acetyl-CoA carboxylase. J. Biol. Chem. 269: 14438-14445, 1994.
144. Wititsuwannakul, D., and K.-H. Kim. Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase. J. Biol. Chem. 252: 7812-7817, 1977.
145. Witters, L., J. Widmer, A. King, K. Fassihi, and F. Kuhajda. Identification of human acetyl-CoA carboxylase isozymes in tissue and in breast cancer cells. Int. J. Biochem. 26: 589-594, 1994.
146. Witters, L. A., G. Gao, B. E. Kemp, and B. Quistorff. Hepatic 5′-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states. Arch. Biochem. Biophys. 308: 413-419, 1994.
147. Witters, L. A., T. D. Watts, D. L. Daniels, and J. L. Evans. Insulin stimulates the dephosphorylation and activation of acetyl CoA carboxylase. Proc. Natl. Acad. Sci. USA 85: 5473-5477, 1988.
148. 2 fixation in metabolism. Essays Biochem. 1: 1-27, 1965.
149. Yang, X., R. Jiang, and M. Carlson. A family of proteins containing a conserved domain that mediates interaction with the yeast SNF1 protein kinase complex. EMBO J. 13: 5878-5886, 1994.
150. Young, M. E., G. K. Radda, and B. Leighton. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR-an activator of AMP-activated protein kinase. FEBS Lett. 382: 43-47, 1996.
151. Zammit, V. Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochemistry 314: 1-14, 1996.
152. Zhang, S., and K.-H. Kim. Essential role of acetyl CoA carboxylase in the glucose-induced insulin secretion in a pancreatic β-cell line. Cell. Signalling 10: 35-42, 1998.